NASDAQ:ONTX
Onconova Therapeutics, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.onconova.comipo date
Jul 25, 2013
Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological malignancies as a single agent or in combination with other ant...Show More
Earnings
Earnings Release in 12 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus